Anastrozole - National Cancer Institute - anastrozole breast prevention


Aromatase Inhibitors for Lowering Breast Cancer Risk anastrozole breast prevention

Mar 22,  · BACKGROUND: Aromatase inhibitors effectively prevent breast cancer recurrence and development of new contralateral tumours in postmenopausal women. We assessed the efficacy and safety of the aromatase inhibitor anastrozole for prevention of breast cancer in postmenopausal women who are at high risk of the by:

Postmenopausal women at high risk of breast cancer may have a powerful new ally: A new study finds the drug anastrozole (Arimidex®) halves their odds of developing the disease. The drug also seems to have fewer side effects than other preventive medicines such as tamoxifen or raloxifene.

Advanced breast cancer that has gotten worse after treatment with tamoxifen citrate. Anastrozole is also being studied in the treatment of other conditions and types of cancer. More About Anastrozole. Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.

Anastrozole effectively reduces incidence of breast cancer in high-risk postmenopausal women. This finding, along with the fact that most of the side-effects associated with oestrogen deprivation were not attributable to treatment, provides support for the use of anastrozole in postmenopausal women at high risk of breast by: